Safety, tolerability and pharmacokinetics of intra-articular (IA) single ascending dose of 4P-004 in patient with Kellgren and Lawrence grade 2 to 4 osteoarthritic (OA) knee
Phase 1
- Conditions
- Knee osteoarthritisMedDRA version: 20.0Level: PTClassification code: 10031161Term: Osteoarthritis Class: 100000004859Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Registration Number
- CTIS2022-500271-31-00
- Lead Sponsor
- 4moving Biotech
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method